Kevin Roberg-Perez

Title: Kevin Roberg-Perez: Innovator in Biological Production

Introduction

Kevin Roberg-Perez is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biological production, particularly in the synthesis of beta-hydroxyisovalerate (βHIV). With a total of 5 patents to his name, Roberg-Perez is recognized for his innovative approaches to enzyme and microorganism applications.

Latest Patents

Roberg-Perez's latest patents focus on the biological production of beta-hydroxyisovalerate using non-natural enzymes and microorganisms. One of his patents describes a method that utilizes a non-natural enzyme to produce βHIV, which exhibits greater synthase activity compared to its wild-type counterpart. This non-natural enzyme can be expressed in microorganisms such as yeast or bacteria, which possess an active βHIV metabolic pathway. The biological derivation of βHIV through this method eliminates toxic by-products and impurities typically associated with chemical production processes. Another patent highlights the use of a non-natural microorganism that hosts the non-natural enzyme, further enhancing the production of βHIV while maintaining purity.

Career Highlights

Throughout his career, Roberg-Perez has worked with prominent companies such as Cargill Inc. and Sasya Inc. His experience in these organizations has allowed him to develop and refine his innovative techniques in biological production.

Collaborations

Roberg-Perez has collaborated with notable professionals in his field, including Aristos Aristidou and Kari Koivuranta. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kevin Roberg-Perez is a distinguished inventor whose work in the biological production of beta-hydroxyisovalerate showcases his innovative spirit and dedication to advancing the field. His contributions continue to impact the industry positively.